Author:
Bousman Chad A.,Brown Lisa C.,Singh Ajeet B.,Eyre Harris A.,Müller Daniel J.
Reference69 articles.
1. Getting pharmacogenomics into the clinic;Abbasi;JAMA,2016
2. Recommendations for HLA-B⁎15:02 and HLA-A⁎31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions;Amstutz;Epilepsia,2014
3. Remission in schizophrenia: Proposed criteria and rationale for consensus;Andreasen;The American Journal of Psychiatry,2005
4. The role of depression pharmacogenetic decision support tools in shared decision making;Arandjelovic;Journal of Neural Transmission (Vienna),2017
5. Comparison of the guidelines of the clinical pharmacogenetics implementation consortium and the Dutch pharmacogenetics working group;Bank;Clinical Pharmacology and Therapeutics,2017